文献速递肿瘤 PET/CT

乏氧PET纹理特征可预测头颈癌放化疗期间生存

Textural features of hypoxia PET predict survival in head and neck cancer during chemoradiotherapy.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2019-11-26

本研究在29例T1-4、N+、M0头颈鳞癌患者中,于放化疗前及放化疗中系列行[18F]FMISO-PET,评估肿瘤乏氧的纹理特征能否预测临床结局。结果显示,仅部分二阶纹理特征(udiff及灰度游程矩阵非均匀性)可区分预后组,低值与更好总生存相关;一阶指标及放化疗前FDG-PET均未预测结局。

要点

  • FMISO-PET二阶纹理特征可区分头颈鳞癌放化疗预后组。
  • udiff低值及放化疗前至第2周udiff下降与更好总生存相关。
  • 一阶指标及放化疗前FDG-PET未预测总生存。

核心结论

  • 放化疗前及第2周FMISO-PET纹理特征可识别总生存更好的头颈鳞癌患者,提示肿瘤乏氧程度更均匀可能与放化疗后更好结局相关。

研究设计与样本

  • 前瞻性试验的初步评估,纳入29例T1-4、N+、M0头颈鳞癌患者,放化疗前及放化疗中系列行FMISO-PET,放化疗前另行FDG-PET并以FDG-PET定义肿瘤区域。

主要发现

  • 中位随访29.6个月(95%CI:16.8-48.0个月)内,任何FMISO-PET扫描的一阶指标均未以显著分组分离预测总生存(均p>0.05)。
  • 放化疗前udiff(p=0.03,HR=10.8)及放化疗第2周udiff(p=0.05,HR=5.2)可分离预后组,低值与更好总生存相关。
  • 第2周灰度游程矩阵非均匀性可分离预后组(p=0.05,HR=5.3),低值与更好总生存相关。
  • 放化疗前至第2周udiff下降与更好总生存相关(p=0.04,HR=9.4)。
  • 放化疗前FDG-PET在任何测量指标上均未预测结局。

关键数值与推荐

  • 预后评估采用中位数分割进行组间分离,Kaplan-Meier估计并以log-rank检验(p≤0.05)及组相对风险比(HR)量化与总生存的相关性。

临床怎么用

  • 可考虑在放化疗前及第2周利用FMISO-PET纹理特征(如udiff、灰度游程矩阵非均匀性)辅助识别预后更好的头颈鳞癌患者。
  • 一阶指标及放化疗前FDG-PET在本研究中未显示预后价值,不宜单独用于预后分层。

局限性

  • 本研究为前瞻性试验的初步评估,样本量29例,结果需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The aim of this study was to investigate whether textural features of tumour hypoxia, assessed with serial [18F]fluoromisonidazole (FMISO)-PET, were able to predict clinical outcome in patients with head and neck squamous cell carcinoma (HNSCC, T1-4, N+, M0) during chemoradiotherapy (CRT). METHODS: In a preliminary evaluation of a prospective trial, tumour hypoxia was evaluated in 29 patients via serial FMISO-PET before and during CRT. All patients received an initial [18F]fluorodeoxyglucose (FDG)-PET before CRT, and tumour regions were defined on this FDG-PET. The first-order metrics tumour-to-background ratio (TBRmean, TBRmax, TBRpeak), coefficient of variation, total lesion uptake and integral non-uniformity were calculated for all scans. Further, 3 second-order (textural) features from two grey-level matrices were calculated, as well as differential non-uniformity (udiff). Prognostic value was examined by median split for group separation (GS) in Kaplan-Meier estimates and correlated with overall survival (OS), quantified via log-rank tests (p ≤ 0.05) and group-relative hazard ratios (HR). RESULTS: Within a median follow-up of 29.6 months (95% CI: 16.8-48.0 months), no first-order metrics predicted OS with a significant GS (all p > 0.05) on any FMISO-PET scan. Only udiff before and in week 2 during CRT (p = 0.03, HR = 10.8 and p = 0.05, HR = 5.2) and non-uniformity from grey-level run length matrix in week 2 separated prognostic groups (p = 0.05, HR = 5.3); lower values were correlated with better OS. Further, the decrease in udiff from before CRT to week 2 was correlated with better OS (p = 0.04, HR = 9.4). FDG-PET before CRT did not predict outcome in any measure. CONCLUSIONS: Textural features on FMISO-PET scans before CRT, in week 2 and, to a limited degree, the change of features during CRT, were able to identify head and neck squamous cell carcinoma patients with better OS, suggesting that a higher homogeneity of the degree of hypoxia in tumours could correlate with a better outcome after CRT.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Sörensen A, Carles M, Bunea H, et al. Textural features of hypoxia PET predict survival in head and neck cancer during chemoradiotherapy. Eur J Nucl Med Mol Imaging. 2019. PMID: 31773233. doi:10.1007/s00259-019-04609-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。